LSTM hosts one of the largest groups of Vector Biologists in the world and has seen rapid expansion in recent years. The group has an unparalleled diverse research portfolio in vector borne diseases (VBDs), from mosquito genomics to health economics, and spans the basic science to translational research pathway. The profile of VBDs has arguably never been so high.
While the global burden of malaria has dramatically declined over the past two decades, there is evidence that these gains are stalling, and new tools are urgently needed. Likewise, emerging vector borne diseases, such as Zika and Dengue, threaten the status quo, particularly in sub-Saharan Africa. The technical expertise, strong collaborations with research partners in disease-endemic countries and commitment to producing the next generation of VBD scientists, puts LSTM in a prime position to tackle these issues.